Reports

354 Results (Page 7 of 15)

Kenya Markets Research Reports

Pharmaceuticals

Kenya Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Analysis

Kenya Methicillin-resistant Staphylococcus Aureus (MRSA) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in governmental and private financing for research and development of novel anti-MRSA medications as well as their improved screening are the main drivers of the growth of the market for treating methicillin-resistant staphylococcus aureus (MRSA). Some of the major key players in this market are Merck & Co., Inc., Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Melinta Therapeutics, Inc., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Microspheres Market Analysis

Kenya microspheres market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Medical science and technology improvements as well as rising usage in the medical business are the main drivers of the market under study. The key players in this market are Nouryon Chemicals Holding B.V., Trelleborg AB, Chase Corporation, Mo SCI Corporation, 3M Co., and Kureha Corporation.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Migraine Drugs Market Analysis

Kenya migraine drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. High alcohol consumption, rising healthcare costs, rising job stress, and rising medicine demand are all expected to drive market expansion. In the years ahead, it is anticipated that there will be a rise in public knowledge of migraines and available treatments which will further act as a driver for Migraine Drugs Market. The major key players in this market are Amgen, Abbott Laboratories, Allergan, Eli Lilly, Pfizer, Inc., AstraZeneca, Johnson and Johnson Services, Inc., and GlaxoSmithKline.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Multiple Myeloma Drugs Market Analysis

Kenya multiple myeloma drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of the illness, new technologies, and improved healthcare systems are a few of the elements boosting the revenue of the worldwide multiple myeloma market. The major key players in this market are Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Genentech Inc. (F. Hoffmann-La Roche Ltd), Novartis AG, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Nanomedicine Market Analysis

Kenya nanomedicine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Shortly, significant advancements and the recent commercialization of goods like mRNA- and liposome-based vaccines are anticipated to fuel the rise of nanomedicines. The major key players in this market are Abbott Laboratories, CombiMatrix Corporation, Celgene Corporation, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Nanotechnology Drugs Delivery Market Analysis

Kenya nanotechnology drugs delivery market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for nanotechnology medication delivery is heavily influenced by factors like expanding public awareness of nanotechnology, an increase in the prevalence of chronic illnesses, technological improvement, and rising government investment in nanotechnology in various emerging nations. The major key players in this market are AbbVie, Inc., Amgen, Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., and Novartis International AG.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya NSCLC Drugs Market Analysis

Kenya NSCLC Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. During the projection period, the global non-small cell lung cancer market will grow due to the rise in cancer cases worldwide. Oral medications are predicted to accelerate market expansion. Given that the majority of medications are accessible in capsule and tablet form and that this is a very practical mode of administration, the category is anticipated to accelerate the global market.The global NSCLC Drugs market’s major key players are AstraZeneca PLC, Roche Holding AG, Bristol-Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., Eli Lilly and Company, Novartis AG, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Johnson & Johnson.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Oncology Biosimilars Market Analysis

Kenya oncology biosimilars market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased incidence of cancer is driving the global market. Furthermore, the market is expanding as more people become aware of the existence of oncology biosimilars. Additionally, the advancements in biosimilar manufacturing technologies and procedures have expanded production capacities. The major key players in this market are Sandoz International GmbH, Celltrion Inc., Pfizer Inc., Amgen Inc., Samsung Bioepis, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Oncology/Cancer Drugs Market Analysis

Kenya oncology/cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally rising cancer rates, rising demand for cutting-edge treatments like targeted medication therapies, an increase in the geriatric population, and pervasive lifestyle behaviors like smoking, drinking, and not exercising will all have a positive impact on the market during the projected period. The major key players in this market are Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Ophthalmic Drugs Market Analysis

Kenya ophthalmic drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The key factors driving the growth of the global ophthalmic drugs market are the rise in the elderly population, the prevalence of eye diseases like glaucoma, cataracts, and macular degeneration, the surge in ophthalmic drug demand, and the increase in investment in R&D activities by different healthcare companies. The major key players in this market are Pfizer Inc., Alcon, Novartis AG, Bausch Health Companies Inc., Merck & Co., Inc., Regeneron Pharmaceuticals Inc., Allergan (AbbVie Inc.), Bayer AG, Genentech, Inc. (F. Hoffmann-La Roche Ltd), Nicox, Coherus Biosciences, Inc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Opioid Drugs Market Analysis

Kenya opioid drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The opioid industry is anticipated to rise as a result of expanding painkiller care facilities, altered prescription laws, and intense generic manufacturers' attention on Abuse-Deterrent Formulation (ADF). The major players in this market are Eva Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, and Purdue Pharmaceuticals L.P.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Opioid Pain Management Market Analysis

Kenya opioid pain management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Some of the main factors influencing the market's growth include an increase in the use of these painkillers and an increase in the proportion of the elderly population that is particularly susceptible to orthopaedic pain. Additionally, there has been a significant increase in the number of people worldwide who experience chronic pain. The major key players in this market are Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Opioid Use Disorder Market Analysis

Kenya opioid use disorder market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for opioid use disorders is anticipated to expand in the upcoming years as a result of factors such as an expansion of the patient base and the anticipated introduction of cutting-edge therapies by top firms like Braeburn Pharmaceuticals, BioXcel Therapeutics, MediciNova, AstraZeneca, and others. Some of the major key players in this market are AstraZeneca Plc., BioDelivery Sciences International Inc., Braeburn, Cerebral, Hikma Pharmaceuticals Plc., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Optogenetics Market Analysis

Kenya optogenetics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in the prevalence of neurological illnesses, the rise in optogenetics R&D activities, and the rise in demand for neuroscience research are all contributing factors to the expansion of the optogenetics market. Some of the major key players in this market are Cobalt, Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Oral Anti-Diabetes Drugs Market Analysis

Kenya oral anti-diabetes drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Due to the rise in type 2 diabetes incidence, the market for oral antidiabetic medications is anticipated to have a considerable increase over the forecast period. The adoption of a bad lifestyle, environmental pollution, and a family history of diabetes disease all contribute to the market growth for oral antidiabetic medications. Some of the major key players in this market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Mylan N.V., Fresenius Kabi AG, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Oral Care Market Analysis

Kenya Oral Care Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030.The global increase in dentists in practise, the prevalence of dental illnesses, and technological developments in oral care products are the key drivers of the oral care market. The global Oral Care market’s major key players are Church and Dwight Co. Inc., Lion Corporation, Dentaid, GlaxoSmithKline, Procter and Gamble, Real Teeth Dental Clinic, Roomchang Dental Hospital, Pachem Dental Clinic, Sunstar Suisse S.A., Johnson and Johnson Consumer Inc., Dr. Fresh LLC, Colgate-Palmolive Company.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Oral Contraceptives Market Analysis

Kenya oral contraceptives market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growth drivers for the market are raising awareness of the advantages of oral contraceptives, increasing the proportion of women working, increasing the number of sexually transmitted diseases (STIs), increasing the usage of reversible long-acting contraception (LARCs), Increasing the number of internet pharmacies. Some of the major key players in this market are Allergan plc, Bayer AG, Johnson & Johnson Services, Inc., Mankind Pharma Ltd., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Oral Thin Films Market Analysis

Kenya oral thin films market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Oral thin films market size is being driven by an increase in R&D spending on quickly dissolving oral films and a rise in demand for thin-film drug delivery systems. The capacity of Oral Thin Films (OTFs) to include even poorly soluble medications has led to a significant demand for them. The major key players in this market are MonoSol Rx, Tesa Labtec GmbH, Pfizer, Inc., Novartis AG, and Wolters Kluwer.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Osteoarthritis Drugs Market Analysis

Kenya osteoarthritis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increased prevalence of osteoarthritis, improvements in drug development R&D, increased funding from private and public organisations for the development of the healthcare sector and research centres, and increased demand for cell-based research activities are the main factors driving the growth of the osteoarthritis drugs market. Some of the major key players in this market are Pfizer Inc., Abbvie Inc., Novartis AG, Amgen Inc., Boehringer Ingelheim International GmbH, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Outpatient Rehabilitation Centers Market Analysis

Kenya outpatient rehabilitation centers market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. A few of the key aspects that are projected to drive growth in the global market are the rise in drug addiction instances, the prevalence of chronic diseases, advances in patient care, and rising demand for rehabilitation therapies. Some of the major key players in this market are AIM Health Group Inc., Accelerated Rehabilitation Centers, Ltd, Select Medical Holdings, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Ovarian Cancer Drugs Market Analysis

Kenya ovarian cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is anticipated to develop as a result of the rising number of elderly women, rise in ovarian cancer cases, ease of use of new treatments and therapies, and increase in healthcare spending. Government spending is also accelerating the market's expansion. Some of the major key players in this market are F. Hoffmann-La Roche AG, Amgen Inc., Pfizer, Inc., Clovis Oncology, AstraZeneca, Abbvie Inc., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Pancreatic Cancer Drugs Market Analysis

Kenya pancreatic cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Genetic anomalies including the BRCA2 gene mutation, Lynch syndrome, and familial atypical mole-malignant melanoma (FAMMM) syndrome may increase the risk of cancer running in the family. The dynamics of the market will be impacted by the rising rates of diabetes and obesity, which will raise the risk of pancreatic cancer. Some of the major key players in this market are Eli Lilly and Company, Celgene, Roche, Novartis, Clovis Oncology, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Paracetamol Market Analysis

Kenya paracetamol market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising geriatric populations, expanding emerging markets, expanding R&D efforts in the healthcare industry, and rising technological developments and modernization in the paracetamol production process will all further open up new potential for the paracetamol market. Some of the key players in this market are Bristol Laboratories, GlaxoSmithKline, Mallinckrodt, Venipharm, Novacyl, FarmalíderGroup, bene-Arzneimittel GmbH, Wockhardt UK Ltd.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Parkinson Disease Market Analysis

Kenya parkinson disease market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key business drivers are anticipated to include the high prevalence of Parkinson's disease (PD) in western countries, the aging global population, which is at a high risk of contracting the disease, and the strong pipeline of drugs that treat the condition. Some of the major key players in this market are Sunovion Pharmaceuticals, Adamas Pharmaceuticals, Neurocrine Biosciences, Supernus Pharmaceuticals, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Pediatric Healthcare Market Analysis

Kenya pediatric healthcare market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growth in the number of kids who need special care, greater knowledge of home healthcare, technological advancements, and rising disposable money are the market's main drivers. The life expectancy of newborns has increased as a result of improvements in medical intervention techniques. Some of the major key players in this market are Abbott, AstraZeneca, GlaxoSmithKline, Merck & Co., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up